Form 4: Centessa Pharmaceuticals Executive David Chao Reports Share Disposal for Tax Obligations

David Chao, Chief Administrative Officer of Centessa Pharmaceuticals, disposed of 10,385 ordinary shares on December 31, 2024, to cover tax withholding obligations related to vesting restricted share units.

Summary

• On December 31, 2024, David M Chao, Chief Administrative Officer of Centessa Pharmaceuticals plc, reported a transaction involving the disposal of ordinary shares.
• The transaction involved the withholding of 10,385 shares by the issuer to cover tax obligations associated with the vesting of restricted share units.
• The shares were disposed of at a price of $16.35 per share.
• Following the transaction, Chao directly owns 241,831 ordinary shares.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (disposal of shares for tax obligations) and does not contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Form 4 filings are a routine part of insider trading reporting requirements, providing transparency into the transactions of company executives and directors. This transaction is a common occurrence where shares are withheld to cover tax obligations upon vesting of restricted stock units.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.

Key Dates